Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alaunos Therapeutics (TCRT) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to $28000.0.

  • Alaunos Therapeutics' Other Non Operating Income rose 2173.91% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $79000.0, marking a year-over-year decrease of 6504.42%. This contributed to the annual value of $133000.0 for FY2024, which is 8730.92% down from last year.
  • According to the latest figures from Q3 2025, Alaunos Therapeutics' Other Non Operating Income is $28000.0, which was up 2173.91% from $19000.0 recorded in Q2 2025.
  • Over the past 5 years, Alaunos Therapeutics' Other Non Operating Income peaked at $477000.0 during Q1 2023, and registered a low of -$20000.0 during Q1 2022.
  • Moreover, its 5-year median value for Other Non Operating Income was $37000.0 (2024), whereas its average is $104764.7.
  • In the last 5 years, Alaunos Therapeutics' Other Non Operating Income surged by 1240000.0% in 2022 and then plummeted by 8776.6% in 2024.
  • Over the past 5 years, Alaunos Therapeutics' Other Non Operating Income (Quarter) stood at $2000.0 in 2021, then soared by 12400.0% to $250000.0 in 2022, then plummeted by 57.6% to $106000.0 in 2023, then tumbled by 87.74% to $13000.0 in 2024, then surged by 115.38% to $28000.0 in 2025.
  • Its last three reported values are $28000.0 in Q3 2025, $19000.0 for Q2 2025, and $19000.0 during Q1 2025.